Tissue reaction to dacron velour and titanium fibre mesh used for anchorage of percutaneous devices by Paquay, Y.C.G.J. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/23236
 
 
 
Please be advised that this information was generated on 2018-07-07 and may be subject to
change.
ELSEVIER
Biamataiïals 17 (1‘HHi) 1251-125«  
©  199« Klstivior Hcionco Limitod 
Printed in Great Britain, All rights rtisorvud
0142-9615S/96/$15.00
Y.C.G.J. Paquay, J.E. de Ruijter, J.P.C.M. van der Waerden 
and J.A. Jansen
Department of Oral Function and Prosthetic Dentistry, Laboratory of Biomaterials, Dental School, University of 
Nijmegen, PO Box 9101, 6500 HB Nijmegen, The Netherlands
Dacron,Uj velour is often used to anchor a percutaneous device, like the catheter used in peritoneal 
dialysis. However, exit-site infections complicate this method of dialysis and are supposed to be 
related to the design of the catheter. In animal experiments, a percutaneous device provided with a 
titanium fibre mesh to anchor the implant was not affected by infectious complications. The purpose of 
this study was to compare the differences in soft tissue reaction to Dacron velour and titanium fibre 
mesh under the same experimental conditions. Therefore, we placed implants, provided with either 
Dacron or titanium mesh, subcutaneously in the dorsum of goats. The implants were left In situ for 4 
months. Histological and histomorphological evaluations were performed. It was found that the soft 
tissue response inside the Dacron was mainly inflammatory, while the titanium mesh evoked good 
biocompatible behaviour. We concluded that the limited fibrous tissue ingrowth into the Dacron cuff 
has to be the reason for the observed high failure incidence of a percutaneous device.
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As reported earlier1,2, peritoneal dialysis has some 
important advantages compared to more conventional 
dialysing methods, like haemodialysis. For example, 
peritoneal dialysis is more convenient to the patient,
considering the positive social and medical
implications of this method. Peritoneal dialysis is also 
relatively cheap and simple.
The method of peritoneal dialysis is based on the 
capacity of the peritoneum to exchange fluid and 
metabolic products. Therefore, dialysis fluid has to be 
instilled in the abdominal cavity through a permanent 
percutaneous access device. Most of the currently used 
catheters for peritoneal dialysis consist of a silicone 
tube with porous polyethylene terephthaiate (DacrontHl) 
cuffs attached to it. Unfortunately, access-related 
complications, such as exit-site infections, occur. A 
retrospective and prospective study, as performed in 
our hospital, showed that 35% of the standard 
catheters had to be removed because of infectious 
complications2. In addition, a strong correlation was 
observed between the appearance of exit-site 
infections and recurrent peritonitis2,3.
Though it is known that the design of the dialysis 
catheter is of influence on the incidence of complica­
tions, an ideal peritoneal catheter is still not available. 
Much research has already been performed to develop
a percutaneous device that can be maintained 
functional for lone periods4-™1. The purpose of these 
considerable research efforts was to obtain a tight skin 
seal in the percutaneous area which can prevent the 
downward migration of epidermis and the influx of 
bacteria. To achieve this, the devices were provided 
with a micro- or macroporous anchor, often made of 
Dacron velour. Despite the disappointing results as
described above, this material is still used
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currently available peritoneal 
Therefore, Gokal et al.17 recently emphasized the 
necessity of new improved access devices. This 
research should be focussed on (1) the application of 
more biocompatible materials to avoid foreign body 
response and (2) the design of the subcutaneous 
anchor to diminish motion at the exit-site and reduce 
the number of exit-site infections.
During the last decade in our laboratory, research 
was directed toward a better understanding of 
percutaneous implant failures and the development of 
more successful percutaneous devices18 . These 
experiments have resulted in a percutaneous device 
provided with a subcutaneous flange made of a porous 
sintered titanium fibre mesh structure . Various 
animal experiments have already shown the efficacy of 
our device. For example, it has been proven that: (1) 
ingrowth of connective tissue into the pores of the 
fibre mesh took place, (2) no, or only very limited,
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epidermal downgrowth was present after 6 months of 
implantation and (3) no percutaneous exit-site 
infections occurred. However, no comparative studies 
were performed between the titanium fibre mesh and 
the Dacron velour as used in the original Tenckhoff 
catheter. Consequently, the purpose of this study was 
to compare the differences in soft tissue reaction to 
Dacron velour and titanium fibre mesh under the same 
experimental conditions.
MATERIALS AND METHODS
Implant materials
We used two different types of implants in the 
experiments. One of the implants is shown in Figure 1. 
This implant is a section of the commercially available 
Tenckhoff catheter (Quinton^, Seattle, WA, USA). It 
consists of a silicone tube with a polyethylene 
terephthaiate Dacron cuff attached to it by means of 
Silastic medical Silicone A adhesive. The length of the 
silicone tube is 7 cm. To avoid ingrowth of tissue, both 
endings of the silicone tube are sealed with medical 
grade silicone glue.
Figure 2 shows the other implant used. The device 
consists of two elements: (l) a flange-shaped
component and (2) a holding element
mesh sheet
composed
commerci sintered titanium
fibres. The mesh was fabricated by interengaging and 
intertwining a multiplicity of commercially pure 
titanium fibres. After compression, the fibre structures 
were sintered to bond the fibres at their points of 
contact. The fibre diameter was 50 /im. The volumetric 
porosity was 86% and the weight of the mesh sheet 
was 600 g m~2. The fibre mesh measured 3 cm in 
diameter and the length of the silicone tube was 5 cm. 
The holding element was composed of polychlortri- 
fluoroethylene (PCTFE, a copolymer of ethylene and 
chlortrifluorethylene). To avoid tissue ingrowth, the
element
medical
glue.
Before insertion the implants were sterilized in an 
autoclave.
Implantation procedure
Fourteen healthy, adult (2-3 years of age), female Dutch 
goats weighing about 60 kg were used in the 
experiments. In each goat, four implants were inserted, 
two on the left and two on the right side of the spinal 
column in the soft tissue of the abdominal wall. The 
implants were left in situ for 4 months.
Surgery was performed under general anaesthesia, 
induced by intravenous injection of 25 mg kg-1 
penthobarbital and atropine (0.5 mg per animal). After 
oro-tracheal intubation, anaesthesia was maintained by 
2-3% ethrane through a constant volume ventilator.
To reduce perioperative risk, the
prophylactic antibiotic Albipen was administered for 
3 days starting 1 h postoperatively.
For the insertion of the implants, the animal was
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Figure 1
catheter. Both with the
Part of the commercially available Tenckhoff
Dacron® velour cuffs together 
silicone tube are visible. The arrows mark the area of the 
implant used for the experiment.
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Figure 2 The implant consists of a flange-shaped titanium 
fibre mesh, a polychlortrifluoroethylene holding element 
and a silicone tube. The small plug seals the holding 
element.
immobilized and the region distal to the costal
ridge was shaved, washed and with
povidone-iodine. A longitudinal incision was made 
parallel to the spinal column. to
incision a subcutaneous pocket was
blunt dissection with scissors between
subcutaneous fat layer and the musculus obliquus 
abdominis externus. Centrally in the subcutaneous 
pocket, the muscle was cleft parallel to the muscle 
fibres over a distance of about 0.5 cm and a small 
tunnel was created by blunt dissection. Then, the 
silicone tube was inserted in this tunnel until either 
the titanium fibre mesh or the Dacron cuff was 
situated on top of the muscle layer. Thereafter, the 
wound was closed using resorbable vicryl 2-0
were placed, 28sutures. A total of 56 
implants provided with the titanium fibre mesh and 
28 implants with the Dacron velour cuff.
To assure complete randomization, the position of 
the various implants into the back was based on a split 
plot design. Balancing was done by Latin Square to 
exclude experimental influences.
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Histological evaluation techniques
After 4 months, the animals were killed using an 
overdose of Nembutal011. After killing the animals, the 
implants with their surrounding tissues were excised 
immediately. Following fixation in 10% buffered 
formalin solution, the specimens were dehydrated by 
alcohol series. Subsequently, the tissue specimens 
were trimmed to remove excess tissue and embedded 
in methyl methacrylate. After polymerization, thin 
(10 /im) histological sections were prepared using
■’ÿÿjj m
a sawmg microtomemodified diamond-blade 
technique24. The sections, containing the implants and 
the surrounding tissues attached to them, were stained 
with Methylene Blue and basic fuchsin and examined 
by light microscopy.
To assess the soft tissue response to the implants, 
both histological and histomorphometric evaluations 
were performed. The histological evaluation consisted 
of thorough description of the observed tissue reaction. 
For the histomorphometric evaluation:
1. The mean distance between the individual fibres of 
either the Dacron velour or the titanium mesh was 
measured.
2. The fraction of either Dacron or titanium fibres with 
associated foreign body giant cells was determined 
according to a method described by Schreuders et 
al.25. For this purpose, the histological sections 
were examined at a total magnification of xl6Q by 
light microscopy. In each section, the number of 
Dacron/titanium fibres with associated foreign 
body giant cells was counted inside four different, 
randomly chosen squares, measuring 500 x 500/tm. 
Then, this number was divided by the total number
of Dacron/titanium 
each square.
as determined
3. The tissue response was quantified by counting the 
number of nuclei of macrophages and foreign body 
giant cells in the interstitial tissue. This was 
performed at the four random 
above, only for this histomorphometric analysis we 
used a square measuring 225 x 225 /tm.
4. Earlier evaluations of retrieved human Tenckhoff
catheters revealed a portion of
Dacron velour cuffs was filled with silicone glue. 
To confirm this observation, we measured 
portion of Dacron velour 
ingrowth and compared it to the part of Dacron 
velour filled with silicone glue (Figure 3).
All histomorphometric procedures were performed 
in five representative sections of each implant and 
done blindly by two different operators.
RESULTS
Descriptive light microscopic evaluation
Dacron velour cuff
It appeared that the Dacron cuff was partially filled 
with silicone glue. Further evaluation of the prepared
sections revealed that the tissue to the
silicone tube and the Dacron
response 
cuff was relatively
uniform. The silicone tubes were surrounded by a thin
§
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Figure 3 The portion of Dacron11’ velour available for 
tissue ingrowth (A) compared to the part of Dacron velour 
filled with silicone glue (B). In this figure, 35% of the cuff is 
available for tissue ingrowth. Original magnification x12.5, 
bar — 244/tm.
to medium-thin fibrous tissue capsule 
to 15 layers of cells. The capsule was commonly free 
from inflammatory cells. Most of the Dacron cuffs were 
surrounded by a tissue capsule containing five up to 
25 layers of fibroblasts (Figure 4). Glosse
%Q cuff, inflammatory cells were? occasio
ve c;observed.
fibres were surrounded by a sleeve
g i a n t  c {Figure 5).and foreign
fibres the porosity was 
connective tissue, but this was only the case where an 
appropriate distance between the individual Dacron 
fibres was present.
Titanium fibre mesh
The tissue response to the fibre mesh-provided implants 
was also relatively uniform. The silicone tube 
surrounded by five to 15 layers of fibroblasts, 
polymer (FCTFE) holding element was 
medium-thin fibrous 
layers of cells. The 
inflammatory ce
by a 
16-2 5
observed a to
was commonly free 
the fibre mesh material we
î, containing 5 to
15 layers of fibroblasts (Figure 6). This capsule was free 
from inflammatory cells. Inside the porosity of the
titanium mesh, more mature collagenous connective
MiM
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Figure 4 The Dacron'* cuff is surrounded by a thin fibrous 
tissue capsule. Inside the porosity, strands of fibrous tissue 
are present where an appropriate distance between the 
individual fibres exists. Original magnification x25, 
bar = 120/im.
^Sllt
IIFigure 5 Almost all Dacron"' fibres (arrows) are 
surrounded by a sleeve of macrophages and foreign body 
giants cells. Original magnification x100, bar ~ 30/m
ütHP
Figure 6 The titanium fibre mesh is surrounded by a thin to 
medium-thin fibrous tissue capsule. Original magnification 
x10, bar = 303 ^m.
tissue was found (Figure 7). Occasionally, 
were present in the interstitium and whe
body giant cells were noticed, they were mos 
one side of the fibres.
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Figure 7 Inside the porosity of the titanium mesh, more 
mature collagenous connective tissue was found. Original 
magnification x25, bar = 120/im.
Histomorphometric evaluation
The mean distance between the individual fibres of the 
Dacron velour was 111.6 um. Still, it has to be noted
the ance between the internal fibres was
smaller compared to the peripheral part of the Dacron 
cuff. Inside the titanium fibre meshes, the mean 
distance between the individual fibres was 170.8 ^m.
Second, we determined the ratio of fibres associated 
with foreign body giant cells compared to the total 
number of fibres in the indicated areas. It appeared 
that inside the Dacron velour 91 ± 4% of the fibres 
was associated with foreign body giant cells compared
titanium fibre mean 
of these
to only 23 ± 12%
structure. Statistical analysis  data, using a
to Wilcoxon, revealed 
significantly more fibres in the Dacron velour
cellsbody 
: 0 . 0 0 1 ).compared to the titanium 
Furthermore, we estimated the number of inflamma-
of either the Dacron
countingvelour
nuc
the Dacron velour 83.57 ± 29.50 nuclei and inside the
27.50 i: 11.78 nuclei were counted
y sis of those data, using a 
lo Wilcoxon,
in each area. Statu
accor
ificant (P < 0.001).
Dacron velour 
available for tissue ingrowth. It appeared that the part 
of the cuff filled with silicone glue as 51 ± 17%.
DISCUSSION AND CONCLUSIONS
The s t il d y compare the
:es in s reaction to Dacron velour and
to anchor a
the titanium mesh
,1,21.22
; of inflammatory
cells was
:ron
connective
In addition,
was
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observed. Two explanations can be given for 
difference in tissue behaviour between Dacron 
titanium. First, it can be related to differences in 
surface energetic properties. It is known that, in 
contrast to titanium, Dacron has a low surface tension. 
Biomaterials with low-energy surfaces are reported to 
be less biocompatible. Various in vitro and in vivo 
studies demonstrated the influence of this parameter 
on the foreign body host response26-29. It also 
appeared that radio frequency glow discharge 
treatment of implants, for instance, increases the 
wettability of these materials, resulting in an improved 
fibroblast behaviour to the implant surface. A second 
explanation is based on the findings of Steinemann 
and Mäusli , who described that the biocompatible 
behaviour of titanium occurs because the corrosion
products are at saturation in and
electroneutral. Therefore, an implant made of titanium 
will not effect a local tissue reaction.
In contrast to the difference in tissue reaction inside 
the porosity of the implants, the capsule thickness 
seems not to be influenced by the kind of implant 
material. This is in agreement with the observations 
reported earlier that the thickness of the fibrous 
tissue capsule is the result of the wound healing 
response to the surgical trauma and has no relation 
with the chemical compatibility of the implant
material31,32.
According to Tenckhoff, the Dacron cuff applied in 
dialysis catheters and situated in the subcutaneous 
area fulfils two functions: (1) promotion of fibrous 
tissue ingrowth for fixation of the catheter and (2) 
prevention of bacterial migration along the cuff into 
the subcutaneous area'13. It is also known that the rate 
of epithelial migration alongside a percutaneous 
device appeared to be dependent on the degree of 
migration alongside a percutaneous device appeared to 
be dependent on the degree of connective tissue 
maturity inside the porosity of the implant34. However, 
as our evaluation shows, because of the production
process one-half of the Dacron c 
silicone glue. Furthermore, the
is filled with 
of fibrous
tissue is very limited. After 4 months implantation, the 
remainder of the cuff is mainly filled with inflamma­
tory tissue. Despite a sufficient distance between the 
velour fibres to allow ingrowth, only some strands of
connective 
Dacron cuff fibres. These
studies
2 5 ,3 4 —38
on the
confirmed by
reaction :rori
Combination of these 
with our earlier histological evaluation of experimental 
titanium 
rabbits22
mesh percutaneous devices placed in 
can only lead to the conclusion
limited fibrous tissue ingrowth into the Dacron cuff 
has to be the reason for the observed high 
incidence of this kind of device.
In summary, we assume that both designed functions
percutaneousof the Dacron i.e. fixation
passage seal, will never be obtained in this material. 
As a consequence, exit-site infections and peritonitis 
will continue to be the major complications of 
peritoneal dialysis. In contrast, the tissue reaction to 
the titanium fibre mesh is significantly 
Therefore, a percutaneous device equipped with this
material { 
rates.
be able to the complication
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